Shanghai Fos.Pharm.(Gr.)Co.Ltd Registered Shares H YC 1

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

10.80%

Market Cap

-

P/E Ratio

12.71

Dividend Yield

2.56 %

Earnings per Share

0.16 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE1.815 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 05:33:08 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW1.8251.804
PREV. DAY'S PRICE1.8125 (07/20)
CHANGE DAY BEFORE
+0.00
0.14 %
52 WEEK HIGH / LOW3.092 (09/15)1.6605 (06/26)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.120.130.160.190.22
DIVIDENDS PER SHARE
0.040.040.050.050.07
DIVIDEND YIELD IN %
1.94 %2.64 %2.56 %--
DIVIDEND GROWTH IN %
-36.55 %16.99 %23.39 %--
PRICE - EARNINGS RATIO
15.5511.8012.719.478.32
PRICE - BOOK RATIO
0.820.710.85--
PRICE - SALES RATIO
0.900.801.03--
PRICE - CASH FLOW RATIO
11.977.789.10--
Further Key Figures

Master Data

WKN
A1J68D
ISIN
CNE100001M79
SYMBOL
08HH
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
SHANG.FOS.PHARM.GR.H YC 1
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
0.25 %
6.24 %
-14.42 %
-15.54 %
-10.80 %
-20.89 %
-75.17 %
-13.28 %
HIGH1.881.882.162.263.093.098.682.44
LOW1.761.661.661.661.661.321.321.66

Dividende

pro Aktie

Company profile

Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.